Zhi-jun Wu-Xiao - Concepedia

Author

Zhi-jun Wu-Xiao

Also Known As

Zhi-Jun Wu-Xiao, Zhi-Jun Wuxiao, Zhi-jun Wu-Xiao, Zhi-jun Wuxiao, Zhijun Wuxiao

Publications

128

Citations

H-Index

Concepts

All Affiliations

Zhi-jun Wu-Xiao is an author at Sun Yat-sen University Cancer Center specializing in immunology, pathology, and immunotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	69
2	Immunology	3	3	69
3	Pathology	3	3	69
4	Autoimmunity	2	2	38
5	Autoimmune Disease	1	1	17

Zhi-jun Wu-Xiao

Publications

120

Citations

H-Index

Page 1

	Year	Citations
Serum C-Reactive Protein (CRP) as a Simple and Independent Prognostic Factor in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Ya-Jun Li, Zhiming Li, Yi Xia, PLoS ONE	2013	51
Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in patients with stage IE to IIE extranodal natural killer/T-cell lymphoma: a multicenter retrospective study Hua Wang, Zhi-jun Wu-Xiao, Jiayu Zhu, Leukemia & lymphoma/Leukemia and lymphoma Optimal Chemotherapy RegimenFirst-line ChemotherapyLymphoid NeoplasiaMedicineImmunology	2014	31
A prognostic model based on pretreatment platelet lymphocyte ratio for stage IE/IIE upper aerodigestive tract extranodal NK/T cell lymphoma, nasal type Ke-feng Wang, Bo-yang Chang, Xiao-qin Chen, Medical Oncology Lymphoid NeoplasiaImmunodeficienciesImmunologyPathologyImmune Surveillance	2014	21
Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy Zhongjun Xia, Liang Wang, Zhi-jun Wu-Xiao, OncoTargets and Therapy ImmunodeficienciesImmunologyImmune RegulationPathologyImmunotherapeutics	2015	17

Page 1